Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on July 23
BullFrog AI Holdings (NASDAQ: BFRG) announces an exclusive investor webinar scheduled for July 23, 2025, at 4:15 p.m. ET. The event, hosted by RedChip Companies, will feature CEO Vin Singh discussing the company's AI-driven drug development platforms.
Key highlights include the recently launched BullFrog Data Networks™ Solutions Library, powered by their proprietary bfLEAP™ causal AI engine, and the new bfPREP™ module for automated data processing. The company will also discuss its strategic partnership with Sygnature Discovery, aimed at expanding international presence in the $204 billion biopharma R&D market.
BullFrog AI Holdings (NASDAQ: BFRG) annuncia un webinar esclusivo per investitori previsto per il 23 luglio 2025 alle 16:15 ET. L'evento, organizzato da RedChip Companies, vedrà la partecipazione del CEO Vin Singh che illustrerà le piattaforme di sviluppo farmaceutico basate sull'intelligenza artificiale dell'azienda.
I punti salienti includono la recente introduzione della BullFrog Data Networks™ Solutions Library, alimentata dal loro motore proprietario di AI causale bfLEAP™, e il nuovo modulo bfPREP™ per l'elaborazione automatizzata dei dati. Verrà inoltre presentata la partnership strategica con Sygnature Discovery, finalizzata ad ampliare la presenza internazionale nel mercato della ricerca e sviluppo biofarmaceutica da 204 miliardi di dollari.
BullFrog AI Holdings (NASDAQ: BFRG) anuncia un seminario web exclusivo para inversores programado para el 23 de julio de 2025 a las 4:15 p.m. ET. El evento, organizado por RedChip Companies, contará con la participación del CEO Vin Singh, quien hablará sobre las plataformas de desarrollo farmacéutico impulsadas por IA de la empresa.
Los aspectos destacados incluyen el reciente lanzamiento de la BullFrog Data Networks™ Solutions Library, potenciada por su motor de IA causal propietario bfLEAP™, y el nuevo módulo bfPREP™ para el procesamiento automatizado de datos. La compañía también discutirá su asociación estratégica con Sygnature Discovery, destinada a expandir su presencia internacional en el mercado de I+D biofarmacéutico de 204 mil millones de dólares.
BullFrog AI Holdings (NASDAQ: BFRG)는 2025년 7월 23일 오후 4시 15분(동부시간)에 예정된 독점 투자자 웨비나를 발표했습니다. 이 행사는 RedChip Companies가 주최하며, CEO Vin Singh이 회사의 AI 기반 신약 개발 플랫폼에 대해 설명할 예정입니다.
주요 내용으로는 자체 개발한 bfLEAP™ 인과 AI 엔진을 기반으로 한 최근 출시된 BullFrog Data Networks™ Solutions Library와 자동 데이터 처리용 신규 모듈 bfPREP™가 포함됩니다. 또한 회사는 Sygnature Discovery와의 전략적 파트너십을 통해 2040억 달러 규모의 바이오제약 연구개발 시장에서 국제적 입지를 확대할 계획을 논의할 것입니다.
BullFrog AI Holdings (NASDAQ : BFRG) annonce un webinaire exclusif pour investisseurs prévu le 23 juillet 2025 à 16h15 (heure de l'Est). L'événement, organisé par RedChip Companies, sera animé par le PDG Vin Singh, qui présentera les plateformes de développement pharmaceutique basées sur l'IA de l'entreprise.
Les points forts incluent la récente bibliothèque de solutions BullFrog Data Networks™ Solutions Library, propulsée par leur moteur d'IA causale propriétaire bfLEAP™, ainsi que le nouveau module bfPREP™ pour le traitement automatisé des données. La société discutera également de son partenariat stratégique avec Sygnature Discovery, visant à étendre sa présence internationale sur le marché de la R&D biopharmaceutique de 204 milliards de dollars.
BullFrog AI Holdings (NASDAQ: BFRG) kündigt ein exklusives Investoren-Webinar an, das für den 23. Juli 2025 um 16:15 Uhr ET geplant ist. Die Veranstaltung, veranstaltet von RedChip Companies, wird von CEO Vin Singh geleitet, der die KI-gesteuerten Arzneimittelentwicklungsplattformen des Unternehmens vorstellt.
Zu den Highlights zählen die kürzlich eingeführte BullFrog Data Networks™ Solutions Library, die von ihrer proprietären bfLEAP™ Causal AI Engine angetrieben wird, sowie das neue Modul bfPREP™ für die automatisierte Datenverarbeitung. Das Unternehmen wird zudem seine strategische Partnerschaft mit Sygnature Discovery erläutern, die darauf abzielt, die internationale Präsenz im 204 Milliarden US-Dollar schweren Biopharma-F&E-Markt auszubauen.
- None.
- None.
GAITHERSBURG, Md., July 18, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics,, is pleased to invite investors to a webinar on July 23, 2025, at 4:15 p.m. ET.
The exclusive event, hosted by RedChip Companies, will feature BullFrog AI’s Founder and CEO, Vin Singh. Attendees will gain insights into BullFrog AI’s pioneering role in transforming drug discovery and development through its scalable, AI-driven platforms, including the newly launched BullFrog Data Networks™ Solutions Library, powered by the proprietary bfLEAP™ causal AI engine. Recently expanded with the launch of bfPREP™, a cutting-edge module designed to automate data cleansing and standardization, the Solutions Library offers clients a flexible, plug-and-play toolkit for every phase of the drug development lifecycle. Investors will also learn about BullFrog AI’s strategic global collaborations, including its partnership with leading CRO Sygnature Discovery, which is expected to drive significant revenue growth by expanding the commercial reach of BullFrog Data Networks™ internationally. The company's agile business model and robust recurring revenue potential position BullFrog AI to scale effectively within the rapidly evolving
A live question and answer session will follow the presentation.
To register for the free webinar, please visit: https://www.redchip.com/webinar/BFRG/89548315893
Questions can be pre-submitted to BFRG@redchip.com or online during the live event.
About BullFrog AI
BullFrog AI leverages Artificial Intelligence and machine learning to advance drug discovery and development. Through collaborations with leading research institutions, BullFrog AI uses causal AI in combination with its proprietary bfLEAP™ platform to analyze complex biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials.
For more information visit BullFrog AI at: https://bullfrogai.com.
Safe Harbor Statement
This press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," “could,” “will,” "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; our and our partners’ ability to market and sell our offerings and services, including BullFrog Data Networks™ and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
Contact:
Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
BFRG@redchip.com
FAQ
When is BullFrog AI (NASDAQ:BFRG) hosting its investor webinar?
What will be discussed during the BFRG investor webinar?
How can investors register for the BullFrog AI (BFRG) webinar?
What is the market size for BullFrog AI's target industry?
What are the key products offered by BullFrog AI (BFRG)?
